BUZZ-CVS 因长期高管大卫-乔伊纳(David Joyner)被任命为首席执行官的报告而下跌

Reuters
18 Oct 2024

((自动化翻译由路透提供,请见免责声明 ))

10月18日 - ** CVS Health 股价盘前下跌6.30%至59.63美元

** 据《华尔街日报》报道,CVS 将任命 (link) 长期高管 David Joyner 为新任首席执行官,接替 Karen Lynch 掌舵这家陷入困境的医疗保健巨头。

** CVS没有立即回应路透的置评请求

** 报道称,乔伊纳曾任 CVS Caremark(该公司的药房福利管理机构)总裁和 CVS 执行副总裁,他将于周五接任总裁兼首席执行官一职。

** 截至上次收盘,该公司股价年累计下跌约 20

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10